Related Experiment Video

Updated: Jun 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

The management of pre-hypertension and metabolic syndrome

R Rossi1, A Nuzzo, M G Modena

  • 1Institute of Cardiology, University of Modena and Reggio Emilia, Modena, Italy. rosario.rossi@unimore.it

Minerva Cardioangiologica
|November 28, 2009
PubMed

Insights

New guidelines define "pre-hypertension" (BP 120-139/80-89 mmHg), identifying individuals at high risk for hypertension and cardiovascular disease (CVD). This review explores the link between pre-hypertension and metabolic syndrome (MS), a cluster of CVD risk factors.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Arterial hypertension guidelines introduce "pre-hypertension" (systolic BP 120-139 mmHg or diastolic BP 80-89 mmHg).
  • Individuals with pre-hypertension face increased risk of developing hypertension and cardiovascular disease (CVD).
  • Metabolic syndrome (MS) is a cluster of CVD risk factors, including elevated BP, dyslipidemia, obesity, and impaired glucose regulation, significantly increasing CVD risk.

Purpose of the Study:

  • To elucidate the relationship between pre-hypertension and metabolic syndrome.
  • To describe the pathogenic mechanisms linking these two clinical conditions.

Main Methods:

  • Literature review focusing on the interplay between blood pressure levels and metabolic syndrome components.
  • Analysis of pathogenic mechanisms contributing to cardiovascular disease risk.

Main Results:

  • Pre-hypertension identifies individuals at elevated risk for progression to hypertension and subsequent cardiovascular events.
  • Metabolic syndrome significantly amplifies the risk of cardiovascular disease, with individuals having a 61% higher risk compared to those without MS.
  • The review details the interconnectedness of elevated blood pressure and metabolic dysregulation in driving cardiovascular pathology.

Conclusions:

  • Early identification of individuals with pre-hypertension is crucial for cardiovascular disease prevention.
  • Understanding the pathogenic links between pre-hypertension and MS supports targeted screening and early intervention strategies.
  • Further randomized trials are necessary to evaluate therapeutic benefits in individuals with pre-hypertension.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...